Details:

Alternative Title:
Emerg Infect Dis
Publisher's site:
http://dx.doi.org/10.3201/eid2810.221134|10.1001/jamainternmed.2021.1644|10.1016/j.jfma.2022.02.020|10.1016/j.jmii.2021.12.005|10.3201/eid2803.212027|10.1016/j.lanepe.2021.100249|10.1001/jama.2021.23641|10.1056/NEJMoa2200797|10.1016/j.amepre.2022.02.008|10.3201/eid2804.212037
Personal Author:
Sim, Jun Yi ; Wu, Ping-Sheng ; Cheng, Ching-Feng ; Chao, You-Chen ; Yu, Chun-Hsien
Sim, Jun Yi ; Wu, Ping-Sheng ; Cheng, Ching-Feng ; Chao, You-Chen ; Yu, Chun-Hsien Less -
Description:
Among previously uninfected healthcare workers in Taiwan, mRNA COVID-19 booster vaccine was associated with lower odds of COVID-19 after primary recombinant vaccine. Symptom-triggered testing revealed that tetravalent influenza vaccine was associated with higher odds of SARS-CoV-2 infection. COVID-19 vaccination continues to be most effective against SARS-CoV-2.
Subject:
[+]
COVID-19 Vaccines Health Personnel Humans Influenza Vaccines RNA, Messenger
Source:
Emerg Infect Dis. 2022; 28(10):2126-2130
Pubmed ID:
36037810
Pubmed Central ID:
PMC9514369
Document Type:
Letter
Place as Subject:
Taiwan
Collection(s):
Emerging Infectious Diseases
Main Document Checksum:
[+]
urn:sha256:f7d397909da98c083356f0bf2cc1ceefa1f0cabf3c5d4d897ce22aad77956fb4
Download URL:
https://stacks.cdc.gov/view/cdc/122509/cdc_122509_DS1.pdf
File Type:

Supporting Files

• 	22-1134-F.gif	gif
  	22-1134-F.jpg	jpeg
  	22-1134.nxml	xml

More +